• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Janus Henderson Institutional UK Index Opportunities Trust A Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Janus Henderson Investors
Fund Summary The Fund aims to deliver a return in excess of the FTSE All Share Index, the "reference index", (or such other index as may from time to time replace it) before management fees, while carefully controlling deviation from the reference index.The Fund will invest primarily in shares of UK companies included in the reference index. The Fund™s holdings are principally selected to replicate the components of the reference index. The index will not be identically replicated and this can lead to differences in performance. There are no restrictions on the size of the companies in which the Fund may invest. In addition to seeking to reflect the index, the fund manager will make use of investment strategies aimed at enhancing returns. These seek to generate returns based on differences in the prices of securities issued by, or associated with, companies that form part of the reference index.
Fund code HDUAA
Managers David Elms
Manager Tenure 16 years
Morningstar Category UK Large-Cap Equity
IMA Sector UK All Companies
Fund Size £756 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.69%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.8712
Buy Price £0.8712
Price Change -0.9887%
Price Date 3rd July 2020
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 5th December 2019
Fund Status OPEN
David Elms, Director of Market Neutral & Enhanced Equities, joined Henderson in December 2002. Prior to joining Henderson, David was a founding partner of Portfolio Partners, a boutique asset manager based in Australia, where he was responsible for enhanced index equities, derivatives and high yield fixed income.

3-year Mean Monthly Return: Currently unavailable

Annual Returns Currently Unavailable
Benchmark Performance
(UK Large-Cap Equity)
Currently Unavailable
Time Period Cumulative Benchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day -0.99% -17.46% +16.47%
1 week -0.75% -1.63% +0.87%
1 month -1.50% +17.03% -18.53%
3 months 15.36% -17.71% +33.07%
6 months -17.06% -12.51% -4.55%
1 year Currently unavailable Currently unavailable Currently unavailable
3 years Currently unavailable Currently unavailable Currently unavailable
5 years Currently unavailable Currently unavailable Currently unavailable
10 years Currently unavailable Currently unavailable Currently unavailable
YTD -16.84% -0.55% -16.28%
Since inception -12.43% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
AstraZeneca PLC GBR 5.79%
GlaxoSmithKline PLC GBR 4.28%
HSBC Holdings PLC GBR 3.89%
British American Tobacco PLC GBR 3.80%
Diageo PLC GBR 3.33%
BP PLC GBR 3.18%
Rio Tinto PLC GBR 2.43%
Unilever PLC GBR 2.40%
Royal Dutch Shell PLC B GBR 2.38%
Royal Dutch Shell PLC Class A GBR 2.37%

Currently unavailable